Goals

Goals and Objectives

  • Integrate world-class research groups (University, NHS, MRC) into a nexus; facilitating translation of cancer research developments from clinic to laboratory and back, underpinned by innovative IT; more effectively engaging with patients. Special focus will be placed upon identification of diagnostic, prognostic and predictive biomarkers and targets for new drugs
  • Integration of experimental cancer medicine into a quality assured, accessible centre of excellence will be successful if:
    • investigators subjectively feel it has worked
    • we increase accrual into trials, for example in ovary and prostate
    • we demonstrate added value by grant support for related science underpinning new cancer areas
    • generation of an e-science platform that is fit for purpose and exportable
    • demonstrate most projects and trials have added value by having access to more expert and collegiate input
    • provide better education opportunities and influence public policy makers
 

Centre expertise

  • E-science:
    Expertise will be transferable to other centres, for instance through CancerGrid and or NCRI cancer informatics platform.
  • Proteomics:
    Links already in place through for instance RASOR will provide invaluable expertise for translational cancer biology. Protocols and data generated through this collaboration, for instance predictive biomarkers, will be an asset to the wider community.
  • Tissue banks:
    For example through our links with Roland Wolf in Dundee using our tissue banks to investigate the importance of pharmacogenomics and polymorphisms in predicting individual patient outcomes.